
KERUIHK-0206

Lyophilized PowderProduct image
Growth & Hormone
Tesamorelin
GMPKERUIHK-0206
FDA-approved GHRH analogue for HIV-associated lipodystrophy. Reduces visceral fat and improves body composition.
Product Specifications
- CAS Number
- 218949-48-5
- Catalog Purity
- ≥99.21%
- Form
- Lyophilized Powder
- Catalog Grade
- GMP
Product Details
Tesamorelin specifications
Use the product name, catalog reference and available specifications below when discussing your requirements with our team.
- Product
- Tesamorelin
- Catalog reference
- KERUIHK-0206
- CAS number
- 218949-48-5
- Category
- Growth & Hormone
- Physical form
- Lyophilized Powder
Latest reported batch: Tesamorelin
Batch PB-2026-TES-4311 · Oct 26, 2026
- Sample specification
- 10 mg/vial
- Reported appearance
- White lyophilized powder
- Reported molecular weight / identity
- 5135.80 Da
- Analytical method
- RP-HPLC (214/280 nm) / ESI-HRMS
- Storage stated in this report
- 2–8°C, protect from light
Reported analytical results
- Appearance
- Conforms — White lyophilized powder; no visible particulates or cakingReport specification: White lyophilized powderMethod: Visual inspection
- Reconstitution
- <35 s; clear and colorless; no visible particlesReport specification: Clear solution after reconstitutionMethod: 2.0 mL BWFI; gentle swirling
- HPLC Purity
- 99.52%Report specification: ≥99.0%Method: SOP-HPLC-TES-001-v3
- Molecular Weight (MS)
- 5135.80 Da; +5.84 ppmReport specification: 5135.77 ± 0.50 DaMethod: SOP-MS-TES-002 / ESI-HRMS
Show 7 more test results
- Amino Acid Analysis
- ConformsReport specification: Conforms to Tesamorelin 44-aa sequenceMethod: AAA
- Endotoxin (LAL)
- < 0.15 EU/mgReport specification: < 1.0 EU/mgMethod: USP <85> gel-clot; reporting limit 0.05 EU/mg
- Sterility (USP <71>)
- No microbial growth observedReport specification: No evidence of microbial growthMethod: 14-day sterility test
- Residual Solvents
- Acetonitrile <100 ppm; Dichloromethane <50 ppm; DMF <100 ppmReport specification: ICH Q3C Class 2Method: GC-HS
- Water Content (KF)
- 2.35%Report specification: ≤8.0%Method: Karl Fischer / USP <921>
- Optical Rotation
- −30.4°Report specification: −28° to −33°Method: 20°C; 1% acetic acid in water; c=0.5 g/100 mL
- Peptide Content (AAA)
- 98.2%Report specification: ≥95.0%Method: AAA / nitrogen quantitation
Batch Documentation
Certificates of Analysis
Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.
PB-2026-TES-4311Report product: Tesamorelin · 10 mg/vialOct 26, 2026 · Reported purity: 99.52%View this batch COA
Show 3 earlier reports
Product Inquiry
Request a Tesamorelin quotation
We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.



